India to United Arab Emirates: Axitinib Export Trade Route
India has recorded 13 verified shipments of Axitinib exported to United Arab Emirates, representing a combined trade value of $8.5K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $653 USD. The leading Indian exporter is RIZLIFE HEALTHCARE, which accounts for 36% of total export value with 4 shipments worth $3.1K USD. On the buying side, ARROW GENERAL TRADING FZE is the largest importer in United Arab Emirates with $2.5K USD in purchases. The top 3 suppliers — RIZLIFE HEALTHCARE, KRIPT PHARMACEUTICALS PRIVATE LIMITED, VIDHARBHA PHARMA LLP — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Arab Emirates Axitinib corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $8.5K USD. The route is dominated by RIZLIFE HEALTHCARE, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's axitinib manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $653 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with axitinib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 32.9%, placing it at rank #1 among India's top axitinib export destinations globally.
On the import side, key buyers of Indian axitinib in United Arab Emirates include ARROW GENERAL TRADING FZE, HELIOPOLIS PHARMACEUTICALS, ARROW GENRAL TRADING FZE and 7 others. ARROW GENERAL TRADING FZE is the single largest importer with 2 shipments valued at $2.5K USD.
Route Characteristics
- Average transit
